ライフサイエンスコーパス: myocardial perfusion

1 with low event rates in patients with normal myocardial perfusion.

2 ng SPECT to precisely quantify segment-level myocardial perfusion.

3 content, and increased vessel densities and myocardial perfusion.

4 e injection did not impair coronary flow and myocardial perfusion.

5 ta can lead to misinterpretation of regional myocardial perfusion.

6 D than in those without PTSD, denoting worse myocardial perfusion.

7 aine challenge evokes a sizeable decrease in myocardial perfusion.

8 integration of data on coronary anatomy and myocardial perfusion.

9 onary arteries is the prerequisite of normal myocardial perfusion.

10 essure (DBP) to levels that could compromise myocardial perfusion.

11 opathy (HCM) and is associated with abnormal myocardial perfusion.

12 increased with the extent of abnormality of myocardial perfusion.

13 yocardial strain), coronary artery flow, and myocardial perfusion.

14 There was no change in myocardial perfusion.

15 [N]NH3 imaging was performed to evaluate myocardial perfusion.

16 y showed visually concordant DE and regional myocardial perfusion abnormalities in 31 patients and ab

17 dynamic obstruction, presence and extent of myocardial perfusion abnormalities, and fibrosis.

18 3 DE-negative patients had (apical) regional myocardial perfusion abnormalities.

19 ents (17 men; 69+/-9 years) who had improved myocardial perfusion after the first injection but had r

20 ons about vascular territory distribution in myocardial perfusion analysis are frequently inaccurate

21 n) stress, including 15 subjects with normal myocardial perfusion and 27 patients referred for corona

22 The imaging data of patients with normal myocardial perfusion and 30 patients with mid-sized to l

23 allowing routine, noninvasive assessment of myocardial perfusion and anatomy.

24 injection is associated with improvements in myocardial perfusion and anginal symptoms in patients wi

25 not been systemically validated for absolute myocardial perfusion and coronary flow reserve (CFR) by

26 Quantitative assessment in myocardial perfusion and determination of absolute myoca

27 provided incremental prognostic value beyond myocardial perfusion and ejection fraction data.

28 rteriolar density and significantly improved myocardial perfusion and endothelium-dependent vasorelax

29 ection of autologous CD34+ cells can improve myocardial perfusion and function.

30 (STEMI) is common and results in suboptimal myocardial perfusion and increased infarct size.

31 d MPS underwent rest and adenosine stress 3D myocardial perfusion and late gadolinium enhancement CMR

32 Myocardial perfusion and left ventricular ejection fract

33 Myocardial perfusion and left ventricular function were

34 Absolute quantification of myocardial perfusion and MPR with PET have proven diagno

35 (CMR) and positron emission tomography (PET) myocardial perfusion and myocardial perfusion reserve (M

36 ess-induced and adenosine-induced changes in myocardial perfusion and neurohormonal activation in CHF

37 All subjects had normal myocardial perfusion and no history of coronary artery d

38 armacokinetic studies in mice by quantifying myocardial perfusion and oxygen consumption with (11)C-a

39 Left ventricular myocardial perfusion and sympathetic innervation were as

40 circulation may represent less well-balanced myocardial perfusion and thus confer worse prognosis in

41 This study sought to assess myocardial perfusion and tissue oxygenation during vasod

42 sitive patients demonstrated normal regional myocardial perfusion, and 3 DE-negative patients had (ap

43 levels, left ventricular ejection fraction, myocardial perfusion, and adverse events.

44 ise tolerance, and antianginal medications), myocardial perfusion, and clinical end points.

45 t of myocardial edema, myocardial siderosis, myocardial perfusion, and diffuse myocardial fibrosis.

46 scar, halting adverse remodeling, increasing myocardial perfusion, and improving hemodynamic status a

47 ance (cine, T2* iron, vasodilator first pass myocardial perfusion, and late gadolinium enhancement im

48 s is a cause of cardiac dysfunction, reduced myocardial perfusion, and ultimately heart failure.

49 ry angina is associated with improvements in myocardial perfusion, anginal complaints, and quality of

50 Small-scale studies have shown that myocardial perfusion assessed by SonoVue-enhanced MCE is

51 Myocardial perfusion assessed using single-photon emissi

52 gorithm is helpful for improving accuracy of myocardial perfusion at dynamic volume CT.

53 (A), microvascular flow velocity (beta), and myocardial perfusion (Axbeta).

54 f the physiology of coronary circulation and myocardial perfusion; (b) describe the technical prerequ

55 ress study before the procedure, with stress myocardial perfusion being used most frequently.

56 ascularization) and quantitative measures of myocardial perfusion by [(13)N] ammonia positron emissio

57 ocker therapy has been also shown to improve myocardial perfusion by enhancing neoangiogenesis in the

58 Myocardial perfusion cardiac MR imaging during CPT can a

59 First-pass myocardial perfusion cardiovascular magnetic resonance (

60 cy of dynamic 3-dimensional (3D) whole heart myocardial perfusion cardiovascular magnetic resonance (

61 om nonischemic cardiomyopathy; evaluation of myocardial perfusion; characterization of hypertrophic c

62 3D whole heart myocardial perfusion CMR accurately detects functionally

63 3D myocardial perfusion CMR and MPS agreed in 38 of the 45

64 ent rest and adenosine stress 3D whole heart myocardial perfusion CMR at 3-T.

65 an estimation of ischemic burden by using 3D myocardial perfusion CMR holds promise for noninvasive g

66 3D myocardial perfusion CMR is an alternative to MPS for de

67 3D whole heart myocardial perfusion CMR overcomes the limited spatial c

68 In this multicenter study, 3D myocardial perfusion CMR proved highly diagnostic for th

69 s to assess the diagnostic performance of 3D myocardial perfusion CMR to detect functionally relevant

70 s study was to compare ischemic burden on 3D myocardial perfusion CMR with (99m)Tc-tetrofosmin MPS.

71 More recently developed 3-dimensional (3D) myocardial perfusion CMR, however, provides whole-heart

72 y Score (DJS) and noninvasive 3D whole heart myocardial perfusion CMR.

73 ation of abnormalities including border zone myocardial perfusion, contractile dysfunction, and LV wa

74 blished the feasibility of performing stress myocardial perfusion CT imaging in small groups of patie

75 roups of patients and have shown that stress myocardial perfusion CT in combination with CT coronary

76 se determinants of myocardial oxygen demand, myocardial perfusion decreased by 30% (103.7+/-9.8 to 75

77 Myocardial perfusion decreased significantly during HD a

78 R) is typically based on induction of either myocardial perfusion defect or wall motion abnormality.

79 In 27 studies with a myocardial perfusion defect, relative uptake in the vasc

80 I and CTA data may facilitate correlation of myocardial perfusion defects and subtending coronary art

81 c stress in eliciting clinically significant myocardial perfusion defects in CHF patients.

82 der confidence at cardiac CT angiography, (b)myocardial perfusion defects were identified and scored

83 ry artery luminal stenosis and corresponding myocardial perfusion deficits in patients with suspected

84 In contrast, regions of reduced myocardial perfusion delineated by cardiac ASL were able

85 At baseline, myocardial perfusion differed between the MI core (media

86 ng (CMR) has been shown to be able to detect myocardial perfusion differences.

87 ents in CT technology allow CT evaluation of myocardial perfusion during vasodilator stress, thereby

88 Diagnostic performance of quantitative myocardial perfusion estimates is not affected by the tr

89 nctional MR images and dynamic assessment of myocardial perfusion from transit of intravascular contr

90 magnetic resonance for routine assessment of myocardial perfusion, function, and late gadolinium enha

91 Myocardial perfusion gated SPECT performed 1 month after

92 The incremental prognostic value of myocardial perfusion-gated single photon emission comput

93 as compared with coronary flow reserve, TIMI myocardial perfusion grade, and clinical variables.

94 y artery disease, given concerns for reduced myocardial perfusion if diastolic blood pressure is too

95 Consequently, conventional myocardial perfusion images obtained from whole cardiac

96 SPECT and PET myocardial perfusion images show greater myocardial inte

97 ties were quantified by visual evaluation of myocardial perfusion images.

98 cian offices; this proportion was higher for myocardial perfusion imaging (74.8%) and cardiac compute

99 fusion (CTP) with cardiac magnetic resonance myocardial perfusion imaging (CMR-Perf) for detection of

100 eys the extensive literature on preoperative myocardial perfusion imaging (MPI) and outlines key tren

101 value of positron emission tomography (PET) myocardial perfusion imaging (MPI) and the improved clas

102 CT angiography (CTA) and SPECT myocardial perfusion imaging (MPI) are complementary ima

103 ve patients undergoing adenosine stress-rest myocardial perfusion imaging (MPI) by (99m)Tc-tetrofosmi

104 ate use criteria recommend performing stress myocardial perfusion imaging (MPI) for intermediate- to

105 -photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) has changed over time

106 aluation for appropriate use of radionuclide myocardial perfusion imaging (MPI) in multiple clinical

107 y (CCTA) to a strategy employing rest-stress myocardial perfusion imaging (MPI) in the evaluation of

108 Cardiovascular magnetic resonance (CMR) myocardial perfusion imaging (MPI) is a state-of-the-art

109 -photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) is an effective metho

110 Myocardial perfusion imaging (MPI) is well established i

111 Positron emission tomography (PET) myocardial perfusion imaging (MPI) offers technical bene

112 Radionuclide myocardial perfusion imaging (MPI) plays a vital role in

113 consecutive patients underwent (82)Rubidium myocardial perfusion imaging (MPI) positron emission tom

114 Although SPECT myocardial perfusion imaging (MPI) provides valuable inf

115 segmentation of the left ventricle for SPECT myocardial perfusion imaging (MPI) quantification often

116 lity of a new protocol, IQ SPECT, to acquire myocardial perfusion imaging (MPI) studies in a quarter

117 It remains unclear whether the addition of myocardial perfusion imaging (MPI) to the standard ECG e

118 photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) underwent a comprehen

119 We sought to evaluate the accuracy of myocardial perfusion imaging (MPI) using cadmium-zinc-te

120 Myocardial perfusion imaging (MPI) using nuclear cardiol

121 easibility of attenuation correction (AC) of myocardial perfusion imaging (MPI) with a virtual unenha

122 Hybrid PET myocardial perfusion imaging (MPI) with CT allows the in

123 artery calcium score (CACS) as an adjunct to myocardial perfusion imaging (MPI) with SPECT for cardia

124 Myocardial perfusion imaging (MPI) with SPECT is a well-

125 impact of appropriate use criteria (AUC) for myocardial perfusion imaging (MPI) with SPECT on the est

126 mance for positron emission tomography (PET) myocardial perfusion imaging (MPI) with Tc-99m single-ph

127 The prognostic value of myocardial perfusion imaging (MPI) with the cadmium-zinc

128 -photon emission computed tomography (SPECT)-myocardial perfusion imaging (MPI), a technique that is

129 tunity to lower the injected doses for SPECT myocardial perfusion imaging (MPI), but the exact limits

130 cent advances in CT coronary angiography and myocardial perfusion imaging (MPI), including PET MPI, i

131 Rotenone derivatives have shown promise in myocardial perfusion imaging (MPI).

132 but not in symptomatic patients referred for myocardial perfusion imaging (MPI).

133 r single-photon emission computed tomography myocardial perfusion imaging (MPI).

134 t advantage of PET over conventional nuclear myocardial perfusion imaging (MPI).

135 CCTA or radionuclide stress myocardial perfusion imaging (MPI).

136 h single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI) has improved th

137 t single-photon emission computed tomography-myocardial perfusion imaging (SPECT-MPI) has high predic

138 ween October 2004 and September 2011 who had myocardial perfusion imaging after negative troponin T t

139 own CAD underwent prospectively simultaneous myocardial perfusion imaging and CAC scoring on a hybrid

140 2051 patients who underwent exercise stress myocardial perfusion imaging and echo (5.5+/-7.9 days),

141 The diagnostic accuracy of myocardial perfusion imaging and wall motion imaging wer

142 consecutive CRT recipients with radionuclide myocardial perfusion imaging before CRT between January

143 were Veteran patients who underwent nuclear myocardial perfusion imaging between December 2010 and J

144 +/- 11.8 years), patients were referred for myocardial perfusion imaging between May 2008 and Januar

145 computed tomographic angiography and stress myocardial perfusion imaging by single photon emission c

146 was to determine the diagnostic accuracy of myocardial perfusion imaging by single-photon emission c

147 Contrast material-enhanced myocardial perfusion imaging by using cardiac magnetic r

148 trocardiography, stress echocardiography, or myocardial perfusion imaging can reveal findings associa

149 Myocardial perfusion imaging had good diagnostic accurac

150 Heretofore, radionuclide myocardial perfusion imaging has been primarily qualitat

151 h-spatial-resolution cardiovascular MR (CMR) myocardial perfusion imaging has been shown to be clinic

152 Myocardial perfusion imaging has limited sensitivity for

153 Myocardial perfusion imaging has long been used off labe

154 single-photon emission computed tomographic myocardial perfusion imaging improved from a summed stre

155 high-resolution and standard-resolution CMR myocardial perfusion imaging in patients with suspected

156 Stress myocardial perfusion imaging is a noninvasive alternativ

157 Regadenoson (82)Rb myocardial perfusion imaging is accurate for the detecti

158 Exercise CT myocardial perfusion imaging is feasible and accurate fo

159 Noninvasive myocardial perfusion imaging is increasingly being appli

160 Quantitative myocardial perfusion imaging is increasingly used for th

161 Myocardial perfusion imaging is widely used in the asses

162 is of myocardial dynamic computed tomography myocardial perfusion imaging lacks standardization.

163 atic analysis of dynamic computed tomography myocardial perfusion imaging may permit robust discrimin

164 racy of the 3 most commonly used noninvasive myocardial perfusion imaging modalities, single-photon e

165 h BMI >/= 40 kg/m(2) should be scheduled for myocardial perfusion imaging on a conventional SPECT cam

166 ial blood flow as assessed by stress-induced myocardial perfusion imaging or a significant fall in di

167 mage quality of torso PET and compare stress myocardial perfusion imaging patterns with myocardial (1

168 ought to determine whether changes in stress myocardial perfusion imaging protocols and camera techno

169 (82)Rb myocardial perfusion imaging protocols were implemented

170 significantly higher in patients with normal myocardial perfusion imaging results (6.5% +/- 5.4%) tha

171 econdary outcome was a comparison of nuclear myocardial perfusion imaging results and frequency of is

172 Site scoring of (82)Rb PET myocardial perfusion imaging scans was found to be in go

173 amera system for high-speed SPECT (HS-SPECT) myocardial perfusion imaging shows excellent correlation

174 -photon emission computed tomography (SPECT) myocardial perfusion imaging studies among patients with

175 ce radiation exposure to patients undergoing myocardial perfusion imaging studies, especially when co

176 ests a reference range of TID for (82)Rb PET myocardial perfusion imaging that is in the range of pre

177 were followed for 6 months after their index myocardial perfusion imaging to determine subsequent rat

178 (18)F-labeled BMS747158 is a novel myocardial perfusion imaging tracer that targets mitocho

179 ombined Noninvasive Coronary Angiography and Myocardial Perfusion Imaging Using 320-Detector Row Comp

180 act of increased body mass on the quality of myocardial perfusion imaging using a latest-generation g

181 duals had undergone rest-dipyridamole (82)Rb myocardial perfusion imaging using PET.

182 n spent nuclear fuel cycle as well as toward myocardial perfusion imaging utilizing (82)Sr/(82)Rb iso

183 risk stratification over clinical and gated myocardial perfusion imaging variables.

184 CT myocardial perfusion imaging was performed within 1 minu

185 single-photon emission computed tomographic myocardial perfusion imaging were included.

186 ardiography, stress echocardiography, and/or myocardial perfusion imaging were performed to identify

187 g coronary angiogram within 4 mo after SPECT myocardial perfusion imaging were reviewed.

188 adenosine-stress dynamic computed tomography myocardial perfusion imaging with a second-generation du

189 Stress myocardial perfusion imaging with MRI, computed tomograp

190 Myocardial perfusion imaging with RTMCE may improve the

191 tery disease (CAD) is ambiguous, but nuclear myocardial perfusion imaging with single-photon emission

192 onary artery calcium (CAC) scoring on top of myocardial perfusion imaging with single-photon emission

193 We hypothesized that myocardial perfusion imaging would be low yield with lim

194 CT-FFR, CT myocardial perfusion imaging, and transluminal attenuati

195 se myocardial fibrosis imaging, and absolute myocardial perfusion imaging, are poised to further adva

196 We assessed the incidence of abnormal myocardial perfusion imaging, coronary angiography, reva

197 For gated SPECT myocardial perfusion imaging, when relative activity dis

198 nd software for positron emission tomography myocardial perfusion imaging, which has advanced it from

199 iography, stress echocardiography, or stress myocardial perfusion imaging.

200 on rest/stress positron emission tomography myocardial perfusion imaging.

201 tive to pharmacologic stress or exercise for myocardial perfusion imaging.

202 1 (Tl-201) as an alternative radiotracer for myocardial perfusion imaging.

203 ry angiography and single-photon emission CT myocardial perfusion imaging.

204 d rhodamines as PET radiopharmaceuticals for myocardial perfusion imaging.

205 ositron emission tomography (PET) tracer for myocardial perfusion imaging.

206 lantation, strain-rate echocardiography, and myocardial perfusion imaging.

207 dial infarction showed high concordance with myocardial perfusion in matched territories as revealed

208 s of angina, relevant clinical outcomes, and myocardial perfusion in patients with refractory angina.

209 on, resulting in significant improvements in myocardial perfusion in the setting of chronic ischemia.

210 Infarction occurs when myocardial perfusion is interrupted for prolonged period

211 he early postinfarction period when regional myocardial perfusion is often severely compromised.

212 e relationship between coronary stenosis and myocardial perfusion is well established, little is know

213 ysis was applied to helical multidetector CT myocardial perfusion measurements, the correlation betwe

214 y late gadolinium enhancement (LGE) MRI, and myocardial perfusion/metabolism was evaluated by (99m)Tc

215 onance (CMR) with conventional 2-dimensional myocardial perfusion methods is limited by incomplete ca

216 ], wall motion abnormalities [WMA], abnormal myocardial perfusion, microvascular obstruction, late ga

217 The addition of myocardial perfusion (MP) imaging during dipyridamole re

218 Myocardial perfusion MR estimates of stress MBF and MPR

219 No differences in myocardial perfusion or adverse events were observed bet

220 criteria for identifying areas of decreased myocardial perfusion or for assessing tissue viability f

221 or significantly altering quantification of myocardial perfusion or LV function.

222 ary efficacy end point was change in resting myocardial perfusion over 6 months.

223 um (FBnTP) has recently been introduced as a myocardial perfusion PET agent.

224 ardial flow reserve (MFR) with (13)N-ammonia myocardial perfusion PET have been implemented for clini

225 diagnostic performance of regadenoson (82)Rb myocardial perfusion PET imaging to detect obstructive c

226 ) underwent clinically indicated rest-stress myocardial perfusion PET with (82)Rb.

227 ell tolerated and has a unique potential for myocardial perfusion PET.

228 ronary angiography after stress testing with myocardial perfusion positron emission tomography and wi

229 years, 50.5% women) referred for rest/stress myocardial perfusion positron emission tomography scans

230 or suspected CAD with troponin before stress myocardial perfusion positron emission tomography were f

231 ronary angiography after stress testing with myocardial perfusion positron emission tomography were f

232 ield in sucrose (SUC) versus EtOH; P=0.004), myocardial perfusion (ratio of blood flow to the at-risk

233 Stress myocardial perfusion Rb-82 PET is a diagnostic alternati

234 l blood-derived mononuclear cells (PBMCs) on myocardial perfusion recovery by using cardiac magnetic

235 <2.0, 3.18+/-1.42 mm Hg/cm per second versus myocardial perfusion reserve >/=2.0, 2.24+/-1.19 mm Hg/c

236 with decreased myocardial blood flow on PET (myocardial perfusion reserve <2.0, 3.18+/-1.42 mm Hg/cm

237 Myocardial perfusion reserve (MPR) index was calculated

238 Quantification of myocardial perfusion reserve (MPR) is an emerging topic

239 on tomography (PET) myocardial perfusion and myocardial perfusion reserve (MPR) measurements in patie

240 nalysis for each method, with stress MBF and myocardial perfusion reserve (MPR) serving as continuous

241 MBF and myocardial perfusion reserve (MPR) were calculated for e

242 magnitude of change was proportional to the myocardial perfusion reserve (rho = 0.53; p < 0.01).

243 Signal intensity change (SIDelta) and myocardial perfusion reserve index (MPRI) were measured

244 perfusion images was completed to determine myocardial perfusion reserve index (MPRI).

245 Patients with SCD also had a 21% lower myocardial perfusion reserve index than control subjects

246 nt) were evaluated for perfusion upslope and myocardial perfusion reserve index with Student t test a

247 The CMR myocardial perfusion reserve significantly outperformed

248 ention index to describe global and regional myocardial perfusion reserve using a dedicated solid-sta

249 The CMR myocardial perfusion reserve was the only independent pr

250 Quantification of myocardial perfusion reserve with PET can assist in the

251 fusion cardiac magnetic resonance to measure myocardial perfusion reserve.

252 stress (peak) for the assessment of regional myocardial perfusion (rMP), left ventricular ejection fr

253 erences in the prognostic accuracy of stress myocardial perfusion rubidum-82 (Rb-82) positron emissio

254 The lifetime cancer risk from a single myocardial perfusion scan is small and should be balance

255 which can be acquired during angiography and myocardial perfusion scans.

256 derwent a comprehensive echocardiogram and a myocardial perfusion scintigraphy (MPS) at inclusion.

257 The extent and severity of ischemia on myocardial perfusion scintigraphy (MPS) is commonly used

258 e is progressive and recurring; thus, stress myocardial perfusion scintigraphy (MPS) is widely used t

259 Compared with stress myocardial perfusion scintigraphy (MPS), CCTA was associ

260 Whether abnormal myocardial perfusion scintigraphy (MPS), dobutamine stre

261 yed to determine appropriateness ratings for myocardial perfusion scintigraphy (MPS), stress echocard

262 mean stenosis diameter 55%+/-11%), underwent myocardial perfusion scintigraphy for documentation of r

263 criminative value for myocardial ischemia on myocardial perfusion scintigraphy of all parameters was

264 There was no reduction in ischemic burden on myocardial perfusion scintigraphy or in the safety endpo

265 ying segments of greater perfusion defect on myocardial perfusion scintigraphy.

266 Baseline SR showed good agreement with myocardial perfusion scintigraphy.

267 atients with available rest and stress gated myocardial perfusion single-photon emission computed tom

268 Myocardial perfusion single-photon emission computed tom

269 ardiovascular magnetic resonance while using myocardial perfusion single-photon emission computed tom

270 Compared with myocardial perfusion single-photon emission computed tom

271 ween CE-SSFP and T2-STIR from this study and myocardial perfusion single-photon emission computed tom

272 improve the diagnostic accuracy of automatic myocardial perfusion SPECT (MPS) interpretation analysis

273 myocardial perfusion stress-rest changes in myocardial perfusion SPECT (MPS) studies for the optimal

274 nuation-corrected (AC) and noncorrected (NC) myocardial perfusion SPECT (MPS) with the corresponding

275 easing concern about radiation exposure from myocardial perfusion SPECT (MPS).

276 myocardial wall motion and thickening during myocardial perfusion SPECT are typically assessed separa

277 % underwent both adenosine and mental stress myocardial perfusion SPECT on consecutive days.

278 In myocardial perfusion SPECT, transient ischemic dilation

279 and coronary angiography within 3 months of myocardial perfusion SPECT.

280 rong foundation for the continued success of myocardial perfusion SPECT.

281 f this study was to determine whether stress myocardial perfusion (SPECT) optimized with stress-only

282 rdized MD, 0.331; 95% CI, 0.08 to 0.55), and myocardial perfusion (standardized MD, -0.49; 95% CI, -0

283 DG uptake on torso PET scans is unrelated to myocardial perfusion status.

284 We aimed to improve the quantification of myocardial perfusion stress-rest changes in myocardial p

285 this incongruence when they interpret DE CT myocardial perfusion studies.

286 history of cardiac disease and with a normal myocardial perfusion study had either a low or a very lo

287 photon emission computed tomography (SPECT) myocardial perfusion study underwent coronary CT angiogr

288 alignment of coronary arterial segments and myocardial perfusion territories, designed for the CORE3

289 ariability in coronary anatomy and potential myocardial perfusion territory overlap.

290 ve vascular-ventricular coupling and enhance myocardial perfusion, thereby potentially contributing t

291 Myocardial perfusion under vasodilator stress is impaire

292 , whereas CMR offers detailed assessments of myocardial perfusion, viability, and function.

293 The summed difference score for regional myocardial perfusion was also assessed.

294 Myocardial perfusion was assessed during rest, peak CPT,

295 Myocardial perfusion was assessed with stress perfusion

296 dioxide (PetCO2) increased by 10 mm Hg, and myocardial perfusion was monitored with myocardial blood

297 Myocardial perfusion was quantified automatically for le

298 Myocardial perfusion was quantified using H2 (15)O PET.

299 CT scans of 10 patients with normal regional myocardial perfusion were analyzed.

300 mL/min/g; p = 0.03), whereas differences in myocardial perfusion were not statistically significant